From the publishers of JADPRO

Biomarkers in NSCLC Resource Center

Advertisement

Perceptions of Biomarker Testing for Underserved Patients With Lung Cancer: A Mixed-Methods Survey of US-Based Oncology Clinicians

Less than half of community oncologists surveyed indicated that they use biomarker testing to guide patient discussions compared with 73% of academic clinicians, according to a report by Boehmer et al presented at the International Association for the Study of Lung Cancer (IASLC) 2021 World Conference on Lung Cancer.

International Association for the Study of Lung Cancer
Advertisement
News & Literature Highlights
Advertisement
Advertisement